Institutional members access full text with Ovid®

Share this article on:

Patch Testing With the Standard Series When Receiving Immunosuppressive Medications

Wentworth, Ashley B. BA*; Davis, Mark D.P. MD

doi: 10.1097/DER.0000000000000048
Studies

Background Debate surrounds the validity of patch testing for allergic contact dermatitis in patients taking immunosuppressants and the extent to which these medications suppress patch test reactions. Previous studies have demonstrated that corticosteroids can suppress immune reactions measured in patch testing. Because immunomodulators are increasingly used, their impact on patch testing also requires evaluation.

Objectives This study aimed to report patch test results in patients taking specific immunosuppressants and to review relevant literature.

Methods A retrospective review of patients patch tested with the standard series at Mayo Clinic in Rochester, Minnesota, between January 1, 2008, and December 31, 2011, was conducted.

Conclusions Positive patch test results occur during methotrexate therapy. How reactions would differ with no immunosuppression is unclear.

From the *Mayo Clinic College of Medicine, Mayo Medical School; and †Department of Dermatology, Mayo Clinic, Rochester, MN.

Address reprint requests to Mark D.P. Davis, MD, Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail: davis.mark2@mayo.edu.

The authors have no funding or conflicts of interest to declare.

Author Wentworth is a student of Mayo Clinic College of Medicine, Mayo Medical School, Rochester, Minn.

© 2014 American Contact Dermatitis Society
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website